Stanford deploys AI scientist agents to accelerate drug discovery timelines from months to days

Anthropic's hiring of Chad Jones underscores the urgent need for rigorous economic frameworks to navigate AI's existential risks and opportunities. The post Anthropic hires Stanford economist Chad Jones to assess AI risks appeared first on Crypto Briefing.

AI-driven drug discovery could revolutionize healthcare by accelerating research, reducing costs, and personalizing treatments. The post Nvidia and Genentech make the case for AI-driven drug discovery at BIO2026 appeared first on Crypto Briefing.

Nvidia's BioNeMo Agent Toolkit could revolutionize drug discovery by streamlining research processes, but reliability challenges remain. The post Nvidia unveils BioNeMo agent toolkit for AI-driven drug discovery and biology research appeared first on Crypto Briefing.

Mounjaro maker is collaborating with small biotechs on AI as a tool for drug discovery

It was the best of trends, it was the worst of trends. It was the epoch of artificial intelligence,  it was the epoch of artificial inflation.  I’m truly excited to be alive at a time when AI, formerly the stuff of science fiction, is now an everyday reality and promising so many benefits to humankind.  AI is accelerating drug discovery, slashing the cost of protein folding research, diagnosing cancers earlier than human radiologists can, automating the drudgery out of nearly every white-collar job, translating speech across hundreds of languages in real time, and giving the blind a way to see the world through a camera.  AI is giving us all this and so much more. But no amount of techno-optimism can hide the fact that AI is making just about everything more expensive.  While the AI trend is making a tiny number of rich people even richer, the public at large is paying the price through rapidly rising prices; it represents a transfer of wealth from the have-nots to the haves.  AI is a

T-Rex's real-time tactile response could revolutionize robotics, enhancing adaptability in dynamic environments and advancing automation capabilities. The post Researchers from UC Berkeley, Nvidia, and Stanford unveil T-Rex framework for robots to respond to physical contact in real time appeared first on Crypto Briefing.

AI-driven drug discovery's rapid progression to human trials could revolutionize biotech timelines, potentially accelerating medical advancements. The post Absci Corporation progresses ABS-201 into human trials, bolstering AI-driven drug discovery appeared first on Crypto Briefing.

The Stanford professor’s work gives autonomous systems new frameworks for tackling complex tasks.